A world-first double-blind clinical trial led by Professor Suzanne Reeves (UCL Psychiatry) will investigate if a powerful drug used to treat nausea in chemotherapy patients could alleviate hallucinations in people with Parkinson’s.
Read: Mail Online, More: UCL News